Notice of AGM

RNS Number : 8650N

Roquefort Therapeutics PLC

07 June 2022

 

7 June 2022

Roquefort Therapeutics plc

("Roquefort Therapeutics" or the "Company")

Notice of Annual General Meeting

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, has today posted its Notice of Annual General Meeting to Shareholders. The Annual General Meeting is scheduled to take place at the offices of Ince Gordon Dadds LLP, Aldgate Tower, 2 Leman Street, London E1 8QN at 10.00 am on 30 June 2022 .

The Notice of Annual General Meeting and Forms of Proxy can be downloaded from the Company's corporate website at https://www.roquefortplc.com/category/shareholder-documents/

-Ends-

Enquiries:

Roquefort Therapeutics plc
Stephen West (Chairman)	[phone]
Buchanan (Public Relations) Ben Romney / Jamie Hooper / George Beale Optiva Securities Limited (Broker)	[phone]
Christian Dennis	[phone]

For further information on Roquefort Therapeutics, please visit www.roquefortplc.com and @RoquefortTherap on Twitter.

LEI: ‎254900P4SISIWOR9RH34

About Roquefort Therapeutics

Roquefort Therapeutics (LSE:ROQ) is a Main Market listed biotech company developing products through the pre-clinical phase prior to partnering or selling to big pharma. The Company is a pre-clinical biotech company focused on developing first in class Midkine targeting drugs for the treatment of cancer.

Through extensive research resulting in validation through publication in over 1,000 scientific journals, Roquefort Therapeutics has identified the potential to exploit the broad therapeutic potential of Midkine for a number of clinical indications of unmet needs. Roquefort Therapeutics holds an exclusive licence to the largest global IP portfolio on Midkine. The Midkine blocking drug development markets have significant global market potential (in the multi-billion dollars). Roquefort Therapeutic's pre-clinical program is currently underway with an initial focus on cancer.

 

END

 

 

NOASSMFEMEESEDM